Patients with serious or unstable medical illnesses. Patients with laboratory or ECG abnormalities considered clinically significant by the investigator. History of syncope or other syncopal attacks, current evidence of hypovolemia, orthostatic hypotension. Patients who have hydrocephalus, seizure disorder, or history of significant head trauma, stroke, transient ischemic attack, subarachnoid bleeding, brain tumor, encephalopathy, meningitis, Parkinson's disease or focal neurological findings. Female patients who have a positive pregnancy test at screening or are breastfeeding. Patients who are judged to be at significant risk of suicide. Treatment with alpha-1 noradrenergic blockers (terazosin, doxazosin, tamsulosin, alfuzosin, or prazosin) or other prohibited medications. Use of benzodiazepines or other hypnotics or oral or short-acting intramuscular antipsychotic drugs in the 4 hours before study treatment. Patients with agitation caused by acute intoxication, including positive identification of alcohol by breathalyzer or drugs of abuse (with the exception of THC) during urine screening. Participants who agree to use a medically acceptable and effective birth control method. Patients who are in good general health prior to study participation as determined by a detailed medical history, physical examination, 12-lead ECG with rhythm strip, blood chemistry profile, hematology, urinalysis, and in the opinion of the Principal Investigator. Patients who read, understand and provide written informed consent. Patients who have a score of ≥ 4 on at least 1 of the 5 items on the PEC at Baseline. Patients who are judged to be clinically agitated at Screening and Baseline with a total score of ≥ 14 on the 5 items (poor impulse control, tension, hostility, uncooperativeness, and excitement) comprising the PANSS Excited Component (PEC). Patients who have met DSM-5 criteria for bipolar I or II disorder. Male and female patients between the ages of 18 to 75 years, inclusive. Why Should I Register and Submit Results?. These expressions actually 'matchers', instances of the BeanMatcher class. 
Here, we are passing an arbitrary number of expressions into the method. Here is a simple public class LoginPage extends PageObject Copy The Serenity PageObject class provides a number of convenient methods that make accessing and manipulating web elements much easier than with conventional WebDriver test scripts. Serenity automatically injects a WebDriver instance into the page object that you can access via the getDriver() method, although you rarely need to use the WebDriver directly. In Serenity, page objects are just ordinary classes that extend the PageObject class. They are an excellent way of making your web tests more maintainable.
Page Objects are a way of isolating the implementation details of a web page inside a class, exposing only business-focused methods related to that page. If you are working with WebDriver web tests, you will be familiar with the concept of Page Objects. It also provides a number of enhancements to standard Selenium.
#SERENITY 2 DRIVER#
Serenity integrates smoothly with Selenium WebDriver and manages details such as setting up the driver and maintaining the driver instance.
0 kommentar(er)
